May 14, 2020 / 02:10PM GMT
Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst
All right. Thanks, everyone, for joining. I'm Robbie Marcus, the medical device analyst at JPMorgan. Happy to have the CFO of SmileDirectClub, Kyle Wailes, with me today. Thanks, Kyle.
Kyle I. Wailes - SmileDirectClub, Inc. - CFO
Thanks, Robbie. Good to be here.
Questions and Answers:
Robert Justin Marcus - JPMorgan Chase & Co, Research Division - AnalystSo on the back of first quarter earnings yesterday, have a lot of questions that sort of correlate with that and complement your report last night. Maybe we could start, SmileDirectClub actually fits well into this current COVID-19 world. A lot of the patients were choosing to have in-person scans, but in this new world where human interaction has taken a pause, you actually have a great option for patients to straighten their teeth at home with no interaction.
You talked a lot last night about this. You said volumes were down about 40% the past 60 days from pre-COVID